临床药剂师干预对慢性阻塞性肺病患者药物坚持的有效性 - 一项随机对照研究
Thang Nguyen1, Mai Thi Xuan Truong1, Dung Ngoc Lam1
1Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Viet Nam.
Patient education and counseling
|November 6, 2023
概括
药剂师主导的教育显著改善了慢性阻塞性肺病 (COPD) 患者的药物坚持和知识. 这种干预措施改善了疾病管理和患者的结果,特别是在资源有限的环境中.
科学领域:
- 肺部医学 肺部医学
- 临床药房 临床药房
- 健康 结果 研究 研究 结果
背景情况:
- 药物不服药是治疗慢性阻塞性肺病 (COPD) 的一个重大挑战.
- 对于COPD患者来说,最佳的疾病控制通常是由于治疗方案的不良遵守而受到阻碍.
研究的目的:
- 评估药剂师主导的教育干预措施对COPD患者药物服药的有效性.
- 评估这些干预措施对整体COPD管理和患者知识的影响.
主要方法:
- 一个为期1个月的,开放标签的,随机对照研究与COPD门诊患者进行.
- 干预组接受了药剂师提供的关于坚持,疾病和药物知识的教育.
- 使用通用药物坚持度表 (GMAS) 测量了药物坚持度.
主要成果:
- 与对照组 (66.3%) 相比,干预组 (90.1%) 观察到药物坚持的显著改善 (p < 0.001).
- 患者行为障碍的非坚持实质上减少了干预后.
- 在修改后的医学研究委员会 (mMRC) 呼吸障碍和吸入技术的尺度上也注意到了改进.
结论:
- 药剂师主导的教育干预措施有效地提高了COPD患者的药物坚持和知识.
- 这种方法突显了临床药剂师在改善患者遵守和人口健康方面的价值,特别是在像越南这样的资源有限的地区.
更多相关视频
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
217
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
217
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K
COPD: Pathogenesis and Clinical Features
302
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
302
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Drug Therapy
47
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
47
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K


